Temozolomide is an oral chemotherapy drug primarily used in the treatment of certain brain cancers such as glioblastoma multiforme (GBM) and anaplastic astrocytoma. It is an alkylating agent that interferes with the DNA of cancer cells, preventing them from growing and dividing.